Shreyaansh Lifesciences, Jaipur. India

nivolumab and relatlimab-rmbw injection
nivolumab and relatlimab-rmbw injection is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in people aged twelve years of age and older.

Get Access To nivolumab and relatlimab-rmbw injection

Ribociclib-tablets Available Price In India UK Saudi Arabia

nivolumab and relatlimab-rmbw injection

  • API – nivolumab and relatlimab-rmbw injection for intravenous use
  • Packaging – injection
  • Strength – Injection: 240 mg of nivolumab and 80 mg of relatlimab per 20 mL (12 mg and 4 mg per mL) in a single-dose vial. 
  • Manufacturer Name – Bristol-Myers Squibb.

What is nivolumab and relatlimab-rmbw used for?

A combination of nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody, indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma.

The combination was approved for medical use in the United States in March 2022, and in the European Union in September 2022.


    All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.